Update: 05.04.2023
Last week: 12 week 2023 (20.03.2023 - 26.03.2023)
Last full month: February 2023
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 94 154 | -7.0% | 2.6% | -0.1 | 24 092 018 | -6.5% | 3.0% | -0.1 | -5.2% |
| MoM | 412 232 | -20.9% | 2.7% | -0.1 | 112 037 618 | -20.3% | 3.4% | -0.1 | -18.0% |
| YTD | 1 285 326 | -68.4% | 2.8% | -3.3 | 343 628 874 | -56.6% | 3.4% | -2.5 | -30.3% |
| MAT | 7 068 670 | -53.4% | 3.8% | -2.8 | 1 571 384 984 | -42.2% | 3.9% | -2.2 | -18.9% |
| DEXALGIN | |||||||||
| WoW | 17 595 | -2.9% | 0.4% | 0 | 9 202 809 | -3.6% | 1.1% | 0 | -6.1% |
| MoM | 60 185 | -30.1% | 0.3% | -0.1 | 33 026 896 | -27.6% | 1.1% | -0.3 | -12.8% |
| YTD | 205 535 | -65.5% | 0.4% | -0.4 | 110 056 765 | -54.2% | 1.2% | -1 | -24.2% |
| MAT | 1 196 090 | -41.2% | 0.5% | -0.2 | 556 370 979 | -29.6% | 1.4% | -0.6 | -13.2% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 61 990 | -2.4% | 40.6% | -0.2 | 38 222 597 | -3.3% | 49.8% | -0.5 | -2.0% |
| MoM | 202 093 | -11.2% | 38.5% | -1 | 128 123 690 | -13.1% | 48.2% | -2.3 | -8.8% |
| YTD | 639 177 | -58.1% | 39.6% | -20.6 | 406 800 074 | -46.2% | 49.6% | -16.6 | -36.3% |
| MAT | 3 397 867 | -38.6% | 47.7% | -15.8 | 1 859 816 149 | -29.2% | 54.3% | -14.4 | -18.3% |
| ESPUMISAN BABY | |||||||||
| WoW | 22 548 | -0.1% | 29.6% | -0.1 | 17 173 010 | -0.9% | 45.7% | -0.4 | 0.4% |
| MoM | 80 707 | -9.9% | 29.3% | -0.3 | 63 130 353 | -9.6% | 46.6% | -0.1 | -8.9% |
| YTD | 248 072 | -43.8% | 29.4% | -10.5 | 192 890 247 | -27.4% | 46.3% | -7.8 | -23.8% |
| MAT | 1 232 982 | -26.5% | 34.3% | -6.4 | 832 827 025 | -16.2% | 48.3% | -6.8 | -12.9% |
| FASTUM | |||||||||
| WoW | 15 724 | -0.4% | 0.8% | 0 | 9 533 547 | 0.5% | 2.2% | 0.1 | -5.5% |
| MoM | 53 314 | -21.9% | 0.8% | -0.1 | 32 316 268 | -23.0% | 2.2% | -0.4 | -9.2% |
| YTD | 175 159 | -50.5% | 0.9% | -0.6 | 106 637 096 | -38.8% | 2.3% | -0.7 | -17.3% |
| MAT | 862 224 | -37.5% | 0.9% | -0.5 | 478 794 791 | -26.5% | 2.3% | -0.7 | -6.7% |
| IODOMARIN | |||||||||
| WoW | 86 850 | 2.3% | 25.1% | 1.5 | 15 919 849 | 1.5% | 10.5% | 0.7 | -3.6% |
| MoM | 263 479 | 2.2% | 22.3% | 1.5 | 49 430 699 | 3.6% | 9.0% | 1 | -4.5% |
| YTD | 806 250 | -11.8% | 22.3% | 2.1 | 150 024 505 | -14.7% | 8.9% | 0.3 | -20.1% |
| MAT | 3 185 574 | -6.7% | 21.1% | 0 | 614 128 361 | -4.5% | 9.1% | -0.2 | -6.8% |
| LIOTON | |||||||||
| WoW | 18 486 | 0.5% | 1.7% | 0.1 | 23 498 965 | 0.8% | 4.1% | 0.2 | -5.6% |
| MoM | 65 231 | 8.9% | 1.8% | 0.2 | 81 963 965 | 10.6% | 4.7% | 0.7 | -5.6% |
| YTD | 185 971 | -54.8% | 1.6% | -1 | 233 523 894 | -41.4% | 4.3% | -1.1 | -26.7% |
| MAT | 1 026 091 | -41.7% | 2.0% | -0.9 | 1 142 533 232 | -25.3% | 4.3% | -1.3 | -16.0% |
| MEZYM | |||||||||
| WoW | 219 422 | -7.3% | 17.9% | -0.2 | 34 938 883 | -7.6% | 12.2% | -0.5 | -6.3% |
| MoM | 800 140 | -20.3% | 19.4% | -0.2 | 126 219 061 | -19.0% | 13.0% | -0.4 | -19.5% |
| YTD | 2 583 662 | -60.2% | 19.2% | -11.9 | 406 217 766 | -58.7% | 13.1% | -9.2 | -35.5% |
| MAT | 13 444 466 | -40.4% | 22.1% | -8 | 2 067 676 675 | -36.1% | 15.5% | -6.6 | -18.7% |
| MIG 400 | |||||||||
| WoW | 126 242 | -5.3% | 2.5% | 0 | 15 232 519 | -2.5% | 1.8% | 0 | -6.1% |
| MoM | 394 153 | -20.0% | 2.1% | -0.2 | 46 693 631 | -25.9% | 1.6% | -0.3 | -12.8% |
| YTD | 1 315 387 | -48.0% | 2.3% | -1 | 159 859 623 | -45.4% | 1.8% | -0.9 | -24.2% |
| MAT | 7 180 151 | -32.2% | 2.9% | -0.8 | 861 360 851 | -28.2% | 2.2% | -0.8 | -13.2% |
| PROSTAMOL | |||||||||
| WoW | 22 332 | -7.6% | 12.5% | -0.6 | 32 961 299 | -9.2% | 13.5% | -1 | -3.5% |
| MoM | 80 544 | -12.7% | 12.9% | -0.9 | 122 384 313 | -11.5% | 14.6% | -1 | -6.3% |
| YTD | 252 439 | -56.4% | 13.2% | -9.5 | 379 985 641 | -52.8% | 14.8% | -9.4 | -25.2% |
| MAT | 1 219 655 | -43.9% | 15.5% | -8.6 | 1 739 337 383 | -38.5% | 16.6% | -9.2 | -12.9% |
| RESPERO MYRTOL | |||||||||
| WoW | 23 743 | 0.9% | 6.8% | 0.2 | 12 983 217 | -1.7% | 7.5% | -0.1 | -1.4% |
| MoM | 94 189 | -9.2% | 7.0% | -0.2 | 54 780 622 | -6.8% | 8.4% | -0.1 | -6.3% |
| YTD | 279 289 | -42.2% | 7.0% | -3 | 159 360 069 | -27.6% | 8.2% | -1.6 | -17.4% |
| MAT | 1 097 879 | -4.8% | 7.4% | 0.1 | 562 756 301 | 6.6% | 8.0% | 0.6 | -5.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 1 285 326 | -68.4% | 2.8% | -3.3 | 343 628 874 | -56.6% | 3.4% | -2.5 | -30.3% |
| DEXALGIN | 205 535 | -65.5% | 0.4% | -0.4 | 110 056 765 | -54.2% | 1.2% | -1 | -24.2% |
| ESPUMISAN (ADULTS) | 639 177 | -58.1% | 39.6% | -20.6 | 406 800 074 | -46.2% | 49.6% | -16.6 | -36.3% |
| ESPUMISAN BABY | 248 072 | -43.8% | 29.4% | -10.5 | 192 890 247 | -27.4% | 46.3% | -7.8 | -23.8% |
| FASTUM | 175 159 | -50.5% | 0.9% | -0.6 | 106 637 096 | -38.8% | 2.3% | -0.7 | -17.3% |
| IODOMARIN | 806 250 | -11.8% | 22.3% | 2.1 | 150 024 505 | -14.7% | 8.9% | 0.3 | -20.1% |
| LIOTON | 185 971 | -54.8% | 1.6% | -1 | 233 523 894 | -41.4% | 4.3% | -1.1 | -26.7% |
| MEZYM | 2 583 662 | -60.2% | 19.2% | -11.9 | 406 217 766 | -58.7% | 13.1% | -9.2 | -35.5% |
| MIG 400 | 1 315 387 | -48.0% | 2.3% | -1 | 159 859 623 | -45.4% | 1.8% | -0.9 | -24.2% |
| PROSTAMOL | 252 439 | -56.4% | 13.2% | -9.5 | 379 985 641 | -52.8% | 14.8% | -9.4 | -25.2% |
| RESPERO MYRTOL | 279 289 | -42.2% | 7.0% | -3 | 159 360 069 | -27.6% | 8.2% | -1.6 | -17.4% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 7 068 670 | -53.4% | 3.8% | -2.8 | 1 571 384 984 | -42.2% | 3.9% | -2.2 | -18.9% |
| DEXALGIN | 1 196 090 | -41.2% | 0.5% | -0.2 | 556 370 979 | -29.6% | 1.4% | -0.6 | -13.2% |
| ESPUMISAN (ADULTS) | 3 397 867 | -38.6% | 47.7% | -15.8 | 1 859 816 149 | -29.2% | 54.3% | -14.4 | -18.3% |
| ESPUMISAN BABY | 1 232 982 | -26.5% | 34.3% | -6.4 | 832 827 025 | -16.2% | 48.3% | -6.8 | -12.9% |
| FASTUM | 862 224 | -37.5% | 0.9% | -0.5 | 478 794 791 | -26.5% | 2.3% | -0.7 | -6.7% |
| IODOMARIN | 3 185 574 | -6.7% | 21.1% | 0 | 614 128 361 | -4.5% | 9.1% | -0.2 | -6.8% |
| LIOTON | 1 026 091 | -41.7% | 2.0% | -0.9 | 1 142 533 232 | -25.3% | 4.3% | -1.3 | -16.0% |
| MEZYM | 13 444 466 | -40.4% | 22.1% | -8 | 2 067 676 675 | -36.1% | 15.5% | -6.6 | -18.7% |
| MIG 400 | 7 180 151 | -32.2% | 2.9% | -0.8 | 861 360 851 | -28.2% | 2.2% | -0.8 | -13.2% |
| PROSTAMOL | 1 219 655 | -43.9% | 15.5% | -8.6 | 1 739 337 383 | -38.5% | 16.6% | -9.2 | -12.9% |
| RESPERO MYRTOL | 1 097 879 | -4.8% | 7.4% | 0.1 | 562 756 301 | 6.6% | 8.0% | 0.6 | -5.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 94 154 | -7.0% | 2.6% | -0.1 | 24 092 018 | -6.5% | 3.0% | -0.1 | -5.2% |
| DEXALGIN | 17 595 | -2.9% | 0.4% | 0 | 9 202 809 | -3.6% | 1.1% | 0 | -6.1% |
| ESPUMISAN (ADULTS) | 61 990 | -2.4% | 40.6% | -0.2 | 38 222 597 | -3.3% | 49.8% | -0.5 | -2.0% |
| ESPUMISAN BABY | 22 548 | -0.1% | 29.6% | -0.1 | 17 173 010 | -0.9% | 45.7% | -0.4 | 0.4% |
| FASTUM | 15 724 | -0.4% | 0.8% | 0 | 9 533 547 | 0.5% | 2.2% | 0.1 | -5.5% |
| IODOMARIN | 86 850 | 2.3% | 25.1% | 1.5 | 15 919 849 | 1.5% | 10.5% | 0.7 | -3.6% |
| LIOTON | 18 486 | 0.5% | 1.7% | 0.1 | 23 498 965 | 0.8% | 4.1% | 0.2 | -5.6% |
| MEZYM | 219 422 | -7.3% | 17.9% | -0.2 | 34 938 883 | -7.6% | 12.2% | -0.5 | -6.3% |
| MIG 400 | 126 242 | -5.3% | 2.5% | 0 | 15 232 519 | -2.5% | 1.8% | 0 | -6.1% |
| PROSTAMOL | 22 332 | -7.6% | 12.5% | -0.6 | 32 961 299 | -9.2% | 13.5% | -1 | -3.5% |
| RESPERO MYRTOL | 23 743 | 0.9% | 6.8% | 0.2 | 12 983 217 | -1.7% | 7.5% | -0.1 | -1.4% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 412 232 | -20.9% | 2.7% | -0.1 | 112 037 618 | -20.3% | 3.4% | -0.1 | -18.0% |
| DEXALGIN | 60 185 | -30.1% | 0.3% | -0.1 | 33 026 896 | -27.6% | 1.1% | -0.3 | -12.8% |
| ESPUMISAN (ADULTS) | 202 093 | -11.2% | 38.5% | -1 | 128 123 690 | -13.1% | 48.2% | -2.3 | -8.8% |
| ESPUMISAN BABY | 80 707 | -9.9% | 29.3% | -0.3 | 63 130 353 | -9.6% | 46.6% | -0.1 | -8.9% |
| FASTUM | 53 314 | -21.9% | 0.8% | -0.1 | 32 316 268 | -23.0% | 2.2% | -0.4 | -9.2% |
| IODOMARIN | 263 479 | 2.2% | 22.3% | 1.5 | 49 430 699 | 3.6% | 9.0% | 1 | -4.5% |
| LIOTON | 65 231 | 8.9% | 1.8% | 0.2 | 81 963 965 | 10.6% | 4.7% | 0.7 | -5.6% |
| MEZYM | 800 140 | -20.3% | 19.4% | -0.2 | 126 219 061 | -19.0% | 13.0% | -0.4 | -19.5% |
| MIG 400 | 394 153 | -20.0% | 2.1% | -0.2 | 46 693 631 | -25.9% | 1.6% | -0.3 | -12.8% |
| PROSTAMOL | 80 544 | -12.7% | 12.9% | -0.9 | 122 384 313 | -11.5% | 14.6% | -1 | -6.3% |
| RESPERO MYRTOL | 94 189 | -9.2% | 7.0% | -0.2 | 54 780 622 | -6.8% | 8.4% | -0.1 | -6.3% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"
## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"
## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"
## [1] "ESPUMISAN (ADULTS)"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"
## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"
## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"
## [1] "ESPUMISAN BABY"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"
## [1] "FASTUM"
## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"
## [1] "LIOTON"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"
## [1] "MEZYM"
## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS 20000 IU #20"
## [1] "MEZYM FORTE COATED TABLETS #20"
## [1] "MEZYM FORTE COATED TABLETS #80"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"
## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS 10000 ED #20"
## [1] "DEXALGIN"
## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"
## [1] "MIG 400"
## [1] "MIG 400 COATED TABLETS 400 MG #10"
## [1] "MIG 400 COATED TABLETS 400 MG #20"
## [1] "PROSTAMOL"
## [1] "PROSTAMOL UNO CAPS 320 MG #30"
## [1] "PROSTAMOL UNO CAPS 320 MG #60"
## [1] "PROSTAMOL UNO CAPS 320 MG #90"
## [1] "IODOMARIN"
## [1] "IODOMARIN 100 TABS 100 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #50"
## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"
## [1] "RESPERO MYRTOL"
## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"
## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs